The U.S. Food and Drug Administration approved Arrowhead Pharmaceuticals' drug for a type of genetic disorder that causes extremely high levels of fat in the bloodstream, the health regulator's ...

The U.S. Food and Drug Administration (FDA) has approved Komzifti (ziftomenib), which is a type of treatment known as a menin inhibitor, for use in adults with relapsed or refractory acute myeloid ...

The FDA has authorized another generic variation of mifepristone. Drugmaker Evita Solutions says the version of this drug will be released in 2026. Last year, the Supreme Court refused to limit access ...

The U.S. Food and Drug Administration (FDA) has approved two new biosimilars as reference products for Prolia (denosumab) and XGEVA® (denosumab): Stoboclo (denosumab-bmwo) and Osenvelt (denosumab-bmwo ...

The updated indication allows the use of Rinvoq prior to the use of tumor necrosis factor blocking agents in certain patients ...

WASHINGTON (AP) — Federal officials have approved another generic version of the abortion pill mifepristone, a regulatory formality that quickly triggered pushback from anti-abortion groups and ...

Moderna announced this weekend that the Food and Drug Administration approved its lower-dose Covid-19 vaccine for adults 65 and older, as well as people ages 12 to 64 with at least one medical ...

Mary Mobley is an editorial fellow in media and public relations at The Heritage Foundation. The U.S. Food and Drug Administration has approved a new abortion drug. The drug, which is a generic ...

Sen. Josh Hawley, R-Mo., accused the Food and Drug Administration (FDA) of endangering women’s health, saying the agency approved another chemical abortion drug without the thorough safety review it ...